U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001956) titled 'The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection' on May 25.
Brief Summary: This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis (RA)
Intervention:
BIOLOGICAL: UTAA91 injection
After signing the informed consent form, eligible subjects will receive an infusion of UTAA91 injectio...